These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 9440709
1. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Bottinelli R, Coviello DA, Redwood CS, Pellegrino MA, Maron BJ, Spirito P, Watkins H, Reggiani C. Circ Res; ; 82(1):106-15. PubMed ID: 9440709 [Abstract] [Full Text] [Related]
2. Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility. Bing W, Redwood CS, Purcell IF, Esposito G, Watkins H, Marston SB. Biochem Biophys Res Commun; 1997 Jul 30; 236(3):760-4. PubMed ID: 9245729 [Abstract] [Full Text] [Related]
3. Mouse model of a familial hypertrophic cardiomyopathy mutation in alpha-tropomyosin manifests cardiac dysfunction. Muthuchamy M, Pieples K, Rethinasamy P, Hoit B, Grupp IL, Boivin GP, Wolska B, Evans C, Solaro RJ, Wieczorek DF. Circ Res; 1999 Jul 09; 85(1):47-56. PubMed ID: 10400910 [Abstract] [Full Text] [Related]
4. Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies. Michele DE, Metzger JM. J Mol Med (Berl); 2000 Jul 09; 78(10):543-53. PubMed ID: 11199327 [Abstract] [Full Text] [Related]
5. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. Bing W, Knott A, Redwood C, Esposito G, Purcell I, Watkins H, Marston S. J Mol Cell Cardiol; 2000 Aug 09; 32(8):1489-98. PubMed ID: 10900175 [Abstract] [Full Text] [Related]